Ironwood Pharmaceuticals (IRWD) Assets Average (2011 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Assets Average of $415.7 million for Q1 2026, up 4.86% sequentially from $396.5 million in Q4 2025, and up 22.61% YoY from $339.1 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Assets Average (2011 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Assets Average for 16 years, with the latest figure at $415.7 million in Q1 2026.
- Quarterly Assets Average rose 22.61% year-over-year to $415.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $415.7 million (up 22.61% YoY) and the FY2025 annual result came in at $373.9 million, down 9.02% from the prior year.
- Assets Average climbed to $415.7 million in Q1 2026 per IRWD's latest filing, from $396.5 million in the prior quarter.
- Over five years, Assets Average peaked at $1.1 billion in Q1 2023 and troughed at $335.1 million in Q2 2025.
- A 5-year average of $633.7 million and a median of $454.9 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2024: Assets Average surged 90.78% in 2022, then sank 59.66% in 2024.
- Over 5 years, Assets Average stood at $1.1 billion in 2022, then slumped by 53.52% to $497.6 million in 2023, then declined by 25.6% to $370.2 million in 2024, then increased by 7.1% to $396.5 million in 2025, then rose by 4.86% to $415.7 million in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $415.7 million, $396.5 million, and $369.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | 5.97 Bn |
| 10 | Ironwood Pharmaceuticals | 668.31 Mn | 589.18 Mn | - | 359.85 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 359.85 Mn |
| Mar 31, 2026 | 415.73 Mn |
| Dec 31, 2025 | 396.48 Mn |
| Sep 30, 2025 | 369.50 Mn |
| Jun 30, 2025 | 335.08 Mn |
| Mar 31, 2025 | 339.06 Mn |
| Dec 31, 2024 | 370.21 Mn |
| Sep 30, 2024 | 392.57 Mn |
| Jun 30, 2024 | 417.22 Mn |
| Mar 31, 2024 | 454.95 Mn |
| Dec 31, 2023 | 497.57 Mn |
| Sep 30, 2023 | 563.64 Mn |
| Jun 30, 2023 | 879.25 Mn |
| Mar 31, 2023 | 1.13 Bn |
| Dec 31, 2022 | 1.07 Bn |
| Sep 30, 2022 | 1.01 Bn |
| Jun 30, 2022 | 1.03 Bn |
| Mar 31, 2022 | 1.11 Bn |
| Dec 31, 2021 | 1.10 Bn |
| Sep 30, 2021 | 1.04 Bn |